Pharmaceutical stocks often need just a single blockbuster drug to make their fortunes.
Though the definition varies, blockbuster drugs are those that generate annual sales of $1 billion or more. The biggest blockbuster drugs can even exceed $100 billion in lifetime sales.
All of the companies on this list have drugs in their pipelines which could eclipse the billion dollar revenue milestone.
A blockbuster drug may be enough to send a smaller company’s stock price skyrocketing. Yet, in a larger pharmaceutical firm, a succession of blockbuster drugs is necessary simply to keep prices stable. Investors should keep that in mind before buying into any of the equities on this list.